Clinical trial
Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to…
NCT00001255 · National Human Genome Research Institute (NHGRI), NIH · Completed
Key facts
| NCT number | NCT00001255 |
|---|---|
| Title | Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study |
| Official title | Treatment of Severe Combined Immunodeficiency Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency With Autologous Lymphocytes of CD34+ Cells Transduced With a Human ADA Gene: A Natural History Study |
| Lead sponsor | National Human Genome Research Institute (NHGRI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Severe Combined Immunodeficiency |
| Intervention type | Drug |
| Interventions | ADA PBSC, ADA Umbilical Cord Blood Cells, Transduced Lymphocytes |
| Enrollment | 10 |
| Start date | Sep 1, 1990 |
| Completion | Jul 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: